MONA WILCKE

 

  Mona Wilcke is the CEO of Stockholm university holding AB. She holds a PhD from Stockholm University in biochemistry and is also founder of Glucox Biotech, a pharmaceutical company focusing on diabetes drug development, where she also operated as CEO for several years. She has set up an investment fund (Sätila Medtech), which invested in several startup companies at the time. Thus, she has a broad experience in business and tech transfer managing, and is yearly dealing with a large number of imperative negotiations and licensing contracts